Major depressive disorder (MDD) is a debilitating mental health condition characterized by persistent low mood, loss of ...

The FDA’s decision marks J&J's Spravato as the first monotherapy for adults with treatment-resistant depression.

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to ...

It's become increasingly clear that the gut microbiome can affect human health, including mental health. Which bacterial ...

Part of you is concerned — after all, you know depression can be serious — but on the other hand, can’t weight loss be a good ...

Following U.S. FDA Priority Review, approval is based on data demonstrating SPRAVATO® alone met its primary endpoint at 4 weeks and led to rapid and superior improvement in depressive symptoms ...

Pristiq (desvenlafaxine) and Effexor (venlafaxine) are SNRIs. Pristiq treats depression, while Effexor treats depression and ...

According to Dr. Alexandra Stratyner, Ph.D., co-founder of Stratyner & Associates Psychology, the winter are blues are very ...

For people with anxiety and depression, these conditions can feel like two sides of the same coin. Researchers are exploring ...

A. Antidepressants are approved for use by the Food and Drug Administration in major depressive disorder, some of them in ...

If you have constantly been feeling depressed with symptoms like feeling distracted and low on energy, it can lead to unsafe ...

Many people believe that their wedding day will be the best day of their life. And it’s understandable to have high ...